Roche COVID-19 antibody test wins FDA approval for emergency use
The serology test promises 100% sensitivity and can help assess patients' immune response to the virus
The serology test promises 100% sensitivity and can help assess patients' immune response to the virus
Join this upcoming webinar to understand how NMR-based metabolomics can provide important information at all stages of the cancer timeline
The molecular test kit promises 100% diagnostic sensitivity and specificity, and is authorized for clinical practice use in Europe
The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company's diagnostic portfolio
Download this white paper from Sartorius to find out how advanced flow cytometry addresses the challenges and demands of modern drug discovery pipelines
OncoSpan range expanded to include FFPE and cfDNA formats to mimic solid tumors and liquid biopsy samples, respectively
The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment
Learn more about how BINDER is helping countless laboratories across the world conduct research into coronavirus.
Collaboration will enable global development, manufacturing and distribution of the vaccine
These models aim to accelerate treatment development prior to clinical trials
The test will be available for qualified laboratories across the European Union by the end of May
Leinco Technologies will co-develop a rapid, point of care, immunodiagnostic test for the detection of the SARS-CoV-2 virus responsible for COVID-19
The German-based biotech company specializes in process development for recombinant vaccines
Automatable, magnetic bead-based, ready-made reagents based on solid phase reversible immobilization technology
The STELLARIS, designed to empower researchers to drive progress in science, is confocal microscopy re-imagined
Learn how one immunology lab upgraded its cell counter to discriminate cells in a mixed population and streamline viability counts
Join this expert webinar to find out about applications for cell-based therapies and biologics using advanced high-throughput flow cytometry
Join this webinar to discover how cytometry can be used to monitor immune responses to new therapeutics and how the Maxpar Direct Immune Profiling System can help meet the demands of your COVID-19 research
Join this webinar to find out more about a powerful method of establishing etiology and pathogenesis of viral disease
The company is offering technical and scientific support along with supply chain continuity and instrument contributions
Following regulatory approval, the first clinical trial of the coronavirus vaccine candidates is said to commence in late April
Pioneering new class of diagnostic product will transform fight against pandemic
Learn how our understanding of neurodegenerative diseases has been transformed by affinity screening technology